Samsung Electronics announced that the irregular heart rhythm notification feature of its health monitor app received FDA clearance. Combined with the app’s existing on-demand ECG function, the feature proactively monitors heart rhythms suggestive of AFib. It all works straight from the user’s wrist through the Samsung Galaxy Watch. “We’re excited to announce that irregular heart […]
AFib
Biosense Webster marks first cases with dual energy ablation tech
Biosense Webster today announced the first cases with its investigational Thermocool SmartTouch SF dual energy catheter for treating AFib. The system enables doctors performing an ablation to toggle between two types of energy: pulsed-field and radiofrequency. It appears to be the Johnson & Johnson MedTech subsidiary’s answer to the dual energy ablation tech coming out […]
Medtronic: Linq monitor boosts AFib detection 10-fold among stroke patients
Medtronic (NYSE:MDT) today announced clinical data demonstrating significant improvements in AFib detection using the Reveal Linq. The study compared the Reveal Linq insertable cardiac monitor (ICM) to patients randomized to standard of care. Those patients did not receive continuous long-term monitoring. Medtronic presented the three-year data at the American Stroke Association’s International Stroke Conference (ISC) […]
ITC rules in favor of AliveCor in patent spat with Apple
AliveCor announced today that the International Trade Commission (ITC) ruled that the Apple Watch infringed its patented technology. Along with the final determination, the ITC issued a limited exclusion disorder (LEO) and a cease and desist order. It set a bond in the amount of $2 per unit of infringing Apple Watches imported or sold […]
Apple scores a win in IP spat with AliveCor
The U.S. Patent Trial and Appeal Board has dealt AliveCor a setback in its intellectual property fight with Apple over the technology behind wearable AFib detection. In a ruling entered yesterday, the PTAB agreed with Apple that AliveCor’s claims around U.S. Patent No. 10,595,731 B2 were unpatentable. The board made the determination based on the […]
Google, Fitbit unveil smartwatch that can detect AFib
Google today unveiled its first full-featured premium smartwatch developed with Fitbit’s health and fitness expertise. In August, Google unveiled its new Fall lineup that included The Fitbit Sense 2. Google said at the time that it marks the company’s “most advanced health-focused smartwatch.” It features more than six days of battery life. The watch aims to […]
HeartBeam enables smartwatch connectivity for heart monitoring
HeartBeam (Nasdaq:BEAT) announced today that it expanded its product portfolio to add arrhythmia detection capabilities to wearables. Santa Clara, California-based HeartBeam said in a news release that it aims to serve the growing cardiac device wearable market. The pipeline advancement allows for the addition of arrhythmia detection capabilities for AFib and other arrhythmia monitoring. The […]
iRhythm stock up on positive news out of CMS
iRhythm Technologies (Nasdaq:IRTC) stock soared today on positive reimbursement news out of CMS as the agency makes 2023 fee schedule proposals. Truist analysts yesterday evening pointed to CMS proposing a national coverage determination (NCD) of $229 for the ZioXT wearable cardiac monitor. When incorporating the geographic physician payment adjustments, the analysts thought the actual payment […]
CoreMap raises $23 million to fund AFib mapping development
CoreMap today announced it closed a $20 million Series B financing to accelerate the development of its cardiac arrhythmia diagnostic technology and launch pilot studies. The Burlington, Vermont–based company said it also closed on a $3 million Series A Milestone financing that was part of its $10.5 million Series A in September 2020. In addition, […]
iRhythm CEO considers costs on the path to profitability
Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind. iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it […]
AtriCure posts Street-beating Q3 results, maintains full-year outlook
AtriCure (NSDQ:ATRC) posted third-quarter results today that beat the consensus forecast on Wall Street and maintained its outlook for the full year. The Mason, Ohio-based atrial fibrillation (AFib) technology developer reported profits of $97.1 million, or $2.11 per diluted share, on sales of $70.5 million for the three months ended Sept. 30. Sales grew 28.7% […]